Another study highlighted that dexamethasone-resistant childhood acute lymphoblastic leukemia (ALL) patients showed lower expression levels of VDAC1 than healthy controls; hence, VDAC1 might be considered a predictor of the chemotherapy response for childhood ALL [201]. This evidence concerns the gene VDAC1 and acute lymphoblastic leukemia.